We hope you will join us?
Royal Papworth Hospital relocated to the Cambridge Biomedical Campus in 2019 to enable collaboration with Addenbrookes and the Research committee on the Campus.
The Heart and Lung Research Institute (HRLI) is now being constructed adjacent to the Royal Papworth Hospital and is a joint venture between Royal Papworth Hospital and The University of Cambridge. It will draw together the highest concentration of world-class physicians, research teams, academia, scientists and industry in Europe to treat patients for chronic cardiovascular and respiratory diseases.
HLRI will mean new treatments will be created, tested and delivered to tackle the biggest causes of premature death in the world all on one site. It has set an ambitious five year target to demonstrate proof-of-concept for at least 10 new drugs or diagnostic approaches in heart and lung diseases.
The HLRI is currently under construction situated next to Royal Papworth Hospital on the Cambridge Biomedical Campus, the largest biotech cluster outside the United States. It will be home to more than 380 scientists and medical professionals with state-of-the-art laboratories in genomics, population sciences, research into cellular mechanisms of disease and translational science. It will also include a special 10 bed clinical research facility where the first-in-patient studies of new treatments can be conducted.
We have the opportunity to show you a virtual site visit of how construction is continuing during the Covid 19 pandemic, kindly provided by SDC, the Main Contractor.
You are invited to a Zoom webinar.
When: Mar 1, 2021 01:00 PM London
Topic: CFCI virtual site visit – Heart and Lung Research Institute
Register in advance for this webinar:
After registering, you will receive a confirmation email containing information about joining the webinar.